Expert Opinion on Drug Safety, Volume 21, Issue 1 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 21, Issue 1 (2022)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Volume 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Drug safety evaluation

Article
Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis
Jun Miyoshi, Minoru Matsuura & Tadakazu Hisamatsu
Pages: 1-8
Published online: 13 Sep 2021
AbstractforSafety evaluation of ustekinumab for moderate-to-severe ulcerative colitis | Full Text | References | PDF (285.6 KB) | EPUB
  • 566 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia
Yajnavalka Banerjee, Anca Pantea Stoian, Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Dragana Nikolic, Alexandros Sachinidis, Ali A. Rizvi, Andrej Janez & Manfredi Rizzo
Pages: 9-20
Published online: 14 Oct 2021
AbstractforInclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia | Full Text | References | PDF (775.9 KB) | EPUB
  • 1171 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma
Alessia Villani, Sonia Sofia Ocampo-Garza, Luca Potestio, Gabriella Fabbrocini, Jorge Ocampo-Candiani, Jorge Ocampo-Garza & Massimiliano Scalvenzi
Pages: 21-29
Published online: 01 Nov 2021
AbstractforCemiplimab for the treatment of advanced cutaneous squamous cell carcinoma | Full Text | References | PDF (250.7 KB) | EPUB
  • 463 Views
  • 11 CrossRef citations
  • 0Altmetric

Review

Article
Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides
Manan Pareek, R. Preston Mason & Deepak L. Bhatt
Pages: 31-42
Published online: 07 Sep 2021
AbstractforIcosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides | Full Text | References | PDF (2.8 MB) | EPUB
  • 4390 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization
Danny S. C. Ng, Mary Ho, Lawrence P.L. Iu & Timothy Y.Y. Lai
Pages: 43-54
Published online: 21 Jul 2021
AbstractforSafety review of anti-VEGF therapy in patients with myopic choroidal neovascularization | Full Text | References | PDF (355.7 KB) | EPUB
  • 415 Views
  • 3 CrossRef citations
  • 0Altmetric
The safety of current treatment options for advanced esophageal cancer after first-line chemotherapy
Go Ikeda, Shun Yamamoto & Ken Kato
Pages: 55-65
Published online: 26 Jul 2021
AbstractforThe safety of current treatment options for advanced esophageal cancer after first-line chemotherapy | Full Text | References | PDF (332.8 KB) | EPUB
  • 3160 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?
Soraya Machado de Jesus, Rafael Santos Santana & Silvana Nair Leite
Pages: 67-81
Published online: 15 Jul 2021
AbstractforComparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety? | Full Text | References | PDF (389.9 KB) | EPUB
  • 201 Views
  • 1 CrossRef citations
  • 0Altmetric

Systematic review

Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study
Jan Van Amsterdam & Wim Van Den Brink
Pages: 83-94
Published online: 01 Jul 2021
AbstractforHarm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study | Full Text | References | PDF (416.6 KB) | EPUB
  • 837 Views
  • 8 CrossRef citations
  • 0Altmetric
A systematic review on pediatric medication errors by parents or caregivers at home
Adriana Lopez-Pineda, Javier Gonzalez de Dios, Mercedes Guilabert Mora, Gema Mira-Perceval Juan & Jose Joaquín Mira Solves
Pages: 95-105
Published online: 12 Jul 2021
AbstractforA systematic review on pediatric medication errors by parents or caregivers at home | Full Text | References | PDF (377.1 KB) | EPUB
  • 403 Views
  • 3 CrossRef citations
  • 0Altmetric

Original research

Article
Medication guide for the perioperative management of oral antineoplastic agents in cancer patients
Cristina Villanueva-Bueno, Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Álvaro Giménez-Manzorro, Almudena Ribed, Belén Marzal-Alfaro, José Luis Revuelta-Herrero, Eva Gonzalez-Haba, Ana Herranz & Maria Sanjurjo
Pages: 107-119
Published online: 12 Aug 2021
AbstractforMedication guide for the perioperative management of oral antineoplastic agents in cancer patients | Full Text | References | PDF (264.3 KB) | EPUB
  • 577 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
No association between recent antibiotic use and risk of rheumatoid arthritis: results from two prospective cohort studies
Yuxing Liu, Bin Xia, Bo Li, Jeffrey A Sparks, Qiangsheng He, Jinqiu Yuan & Benjie Zhou
Pages: 121-126
Published online: 25 Aug 2021
AbstractforNo association between recent antibiotic use and risk of rheumatoid arthritis: results from two prospective cohort studies | Full Text | References | PDF (245.3 KB) | EPUB
  • 160 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data
Valeria Dipasquale, Giuseppe Cicala, Francesca Laganà, Paola Cutroneo, Patrizia Felicetti, Simona Potenza, Giuseppe Trimarchi, Edoardo Spina & Claudio Romano
Pages: 127-132
Published online: 20 Sep 2021
AbstractforAdverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data | Full Text | References | PDF (436.4 KB) | EPUB | Supplemental
  • 340 Views
  • 3 CrossRef citations
  • 0Altmetric

Letter to the Editor

Comment about the safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin
Linlin Wang & Zanling Zhang
Pages: 133-134
Published online: 20 Sep 2021
CitationforComment about the safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin | Full Text | References | PDF (138.1 KB) | EPUB
  • 2605 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Letter to the editor

Reply to letter to the Editor to ‘Comment about the safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin’
Athanasios Tragiannidis & Andreas Groll
Pages: 135-136
Published online: 23 Sep 2021
CitationforReply to letter to the Editor to ‘Comment about the safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin’ | Full Text | References | PDF (127.4 KB) | EPUB
  • 601 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles